KDT501

· KinDex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KDT501, covering 2017-10-20 to 2017-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects [Phase 2]